Patents Represented by Attorney Heller Ehrman White & McAuliffe
  • Patent number: 6703038
    Abstract: A bone substitute material is prepared which comprises a soft matrix, living cells and a setting matrix comprising non-ceramic hydroxyapatite cement. The bone substitute material can be injected minimally invasively into a bone defect with a suitable injection apparatus. In an embodiment, living cells are mixed with a fibrinogen solution and then with a thrombin solution to form the soft matrix, and the soft matrix is mixed with an aqueous solution of non-ceramic hydroxyapatite cement to obtain the bone substitute material which remains unsolidified until after application to a body.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: March 9, 2004
    Assignee: Universitaetsklinikum Freiburg
    Inventors: Dirk Johannes Schaefer, Thomas Kiefer, Gerhard Bjorn Stark, Ulrich Kneser
  • Patent number: 6703202
    Abstract: Methods of determining clinical outcomes in patients suffering from a pathological condition or syndrome are provided. Levels of intracellular gene expression re measured from a clinical sample provided by the patient, and the levels are compared to reference levels. Deviations from reference levels are predictive of clinical outcomes, for example, disease progression or response to therapeutic intervention.
    Type: Grant
    Filed: November 30, 2000
    Date of Patent: March 9, 2004
    Assignee: Oxo Chemie AG
    Inventors: Michael McGrath, Stefan Meuer, Friedrich-Wilhelm Kuehne
  • Patent number: 6699483
    Abstract: The invention relates to a product comprised of specific combinations of cell lines intended for use as an allogeneic immunotherapy agent for the treatment of prostate cancer in humans. The heterogeneity of the immunotherapeutic matches the heterogeneity of the antigenic profile in the target prostate cancer and immunises the recipients with many of the potential TAA and TSA which are expressed at various stages of the disease. The invention discloses a vaccine comprising a combination of three different cell lines prepared from primary or metastatic prostate cancer biopsy material. The cell lines are lethally irradiated utilising gamma irradiation at 50-300 Gy to ensure that they are replication incompetent.
    Type: Grant
    Filed: September 7, 2001
    Date of Patent: March 2, 2004
    Assignee: Onyvax Limited
    Inventors: Angus George Dalgleish, Peter Michael Smith, Andrew Derek Sutton, Anthony Ian Walker
  • Patent number: 6700131
    Abstract: A method of compensating for differences in detective gain between a plurality of different scanning heads in a multiple scanning head imaging plate scanner, comprising: (a) scanning each of the scanning heads across an imaging plate thereby determining the detected signal at successive locations across the imaging plate for each of the scanning heads; (b) calculating an inverse relationship to the detected signal at successive locations across the imaging plate for each of the scanning heads; (c) scanning each of the scanning heads across an imaging plate containing an image thereon, thereby determining an image value at the successive locations across the imaging plate for each of the scanning heads; and (d) applying the inverse relationship to the determined image values at the successive locations across the imaging plate for each of the scanning heads.
    Type: Grant
    Filed: May 2, 2001
    Date of Patent: March 2, 2004
    Assignee: Alara, Inc.
    Inventors: H. Keith Nishihara, Brian P. Wilfley
  • Patent number: 6699687
    Abstract: The present invention provides polypeptide and polynucleotides encoding fluorescent indicators having inserted within a fluorescent moiety a sensor polypeptide. Also provided are methods of using the fluorescent indicator. Circularly permuted fluorescent polypeptides and polynucleotides are also provided.
    Type: Grant
    Filed: May 21, 1999
    Date of Patent: March 2, 2004
    Assignee: The Regents of the University of California
    Inventors: Roger Y. Tsien, Geoffrey Baird
  • Patent number: 6694979
    Abstract: An implantable flow control element is provided which prevents air from entering an isolated portion of a patient's lung. The element may permit air to escape from the isolated portion so that the element acts like a valve. Systems for implanting pulmonary devices are also provided.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: February 24, 2004
    Assignee: Emphasys Medical, Inc.
    Inventors: Mark E. Deem, Bernard H. Andreas, Sunmi Chew, Antony J. Fields, Ronald French, Hanson S. Gifford, III, Ronald R. Hundertmark, Alan R. Rapacki, Douglas S. Sutton, Peter M. Wilson
  • Patent number: 6696248
    Abstract: The present invention relates to synthetic DNA sequences which encode one or more collections of homologous proteins/(poly)peptides, and methods for generating and applying libraries of these DNA sequences. In particular, the invention relates to the preparation of a library of human-derived antibody genes by the use of synthetic consensus sequences which cover the structural repertoire of antibodies encoded in the human genome. Furthermore, the invention relates to the use of a single consensus antibody gene as a universal framework for highly diverse antibody libraries.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: February 24, 2004
    Assignee: Morphosys AG
    Inventors: Achim Knappik, Peter Pack, Liming Ge, Simon Moroney, Andreas PlĂĽckthun
  • Patent number: 6695889
    Abstract: In textile products (e.g. yarns, woven fabrics, knit fabrics) comprising highly crosslinked polyacrylic fibers (made of acrylic fibers by partially hydrolyzing a nitrile group to generate an amido group and a carboxylic acid group), fibers blended with the highly crosslinked polyacrylic fibers can be dyed in an even hue. A pre-dyeing treatment process for such textile products (e.g. yarns, woven fabrics, knit fabrics) comprising highly crosslinked polyacrylic fibers comprises a pretreatment step of immersing the textile product into an acidic solution and treating it at a high temperature and an elevated pressure. A dyeing process comprises the steps of conducting this pre-dyeing treatment process, and thereafter conventionally dyeing fibers blended with the highly crosslinked polyacrylic fibers. A pretreated and undyed textile product and a dyed textile product are obtained by the pre-dyeing treatment process and the dyeing process mentioned above, respectively.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: February 24, 2004
    Assignees: Sakaren Co., Ltd., Mizuno Corp.
    Inventors: Takamasa Sakamoto, Tsutomu Shiotani, Takeshi Ogino
  • Patent number: 6696473
    Abstract: Compounds, compositions and methods for modulating the activity of nuclear receptors are provided. In particular, heterocyclic compounds are provided for modulating the activity of farnesoid X receptor (FXR), liver X receptor (LXR) and/or orphan nuclear receptors. In certain embodiments, the compounds are thiazolidinone derivatives.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: February 24, 2004
    Assignee: X-Ceptor Therapeutics, Inc.
    Inventors: Richard Martin, Brenton Todd Flatt, Jeffrey Dean Kahl, Tie-Lin Wang
  • Patent number: 6697390
    Abstract: A laser system includes a high reflector and an output coupler that define a laser oscillator, which produces a fundamental beam. A harmonic generator is positioned to receive at least a portion of the fundamental beam and produce a harmonic beam. The harmonic generator is configured to operate at a temperature selected to provide a least amount of change of a selected parameter of the harmonic beam for the longest period of time. Harmonic beam parameters can include the size and location of the harmonic beam waist, and the divergence of the harmonic beam.
    Type: Grant
    Filed: February 1, 2002
    Date of Patent: February 24, 2004
    Assignee: Spectra Physics Lasers, Inc.
    Inventors: James D. Kafka, Alan B. Petersen, Karl Markert
  • Patent number: 6696557
    Abstract: The present invention provides nucleic acids encoding AL-2 protein, host cells and vectors containing these nucleic acids, and methods for their use to produce AL-2 protein by recombinant DNA methods.
    Type: Grant
    Filed: April 19, 1996
    Date of Patent: February 24, 2004
    Assignee: Genentech, Inc.
    Inventor: Ingrid W. Caras
  • Patent number: 6692935
    Abstract: The present invention relates to a method for targeted assembly of distinct active peptide or protein domains into a single complex and to such complexes. The invention relates particularly to the fusion of peptide or protein domains to complementary association domains which are derived from a single tertiary or quaternary structure by segmentation. The association domains are designed to assemble in a complementary fashion, thereby providing multifunctional (poly)peptides.
    Type: Grant
    Filed: May 30, 2000
    Date of Patent: February 17, 2004
    Assignee: MorphoSys AG
    Inventors: Peter Pack, Andrei Lupas
  • Patent number: 6693417
    Abstract: A micro-electronic bond degradation sensor includes a sensor substrate having sensor circuitry and a sensor stud and a power stud extending therefrom. The sensor circuitry includes a voltage-to-current amplifier having an input coupled to sensor stud and an output coupled to the power stud. The voltage-to-current amplifier is operable to convert a voltage signal occurring along the sensor stud to a current signal output along the power stud.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: February 17, 2004
    Assignee: Commonwealth of Australia
    Inventor: Alan Wilson
  • Patent number: 6692747
    Abstract: The invention belongs to the field of biologically active peptides specifically stimulating antiviral, antimicrobial and antitumor activity of the human and animal immune system.
    Type: Grant
    Filed: December 27, 2000
    Date of Patent: February 17, 2004
    Assignee: Entopharm Co., Ltd.
    Inventors: Soo In Kim, Sergey Ivanovich Chernysh, German Petrovich Bekker, Natalia Borisovna Makhaldiani, Jules Hoffman, Philippe Bulet
  • Patent number: 6693078
    Abstract: Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs in a mammal.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: February 17, 2004
    Assignee: Genentech, Inc.
    Inventors: Ross G. Clark, Henry B. Lowman, Iain C. A. F. Robinson
  • Patent number: 6693079
    Abstract: Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs in a mammal.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: February 17, 2004
    Assignee: Genentech, Inc.
    Inventors: Ross G. Clark, Henry B. Lowman, Iain C. A. F. Robinson
  • Patent number: 6689356
    Abstract: A recombinant baculovirus is provided with a genetic coding sequence for the production of a foreign protein that is toxic to insects. Preferred are nuclear polyhedrosis viruses, with preferred embodiments having been constructed and expressed in insect cells: BmNPV.AaIT and AcNPV.AaIT. Both embodiments function in insect cells infected therewith so as to have the toxin AaIT (originating from the venom of the scorpion A. australis) secreted. A clone designated (pCIB4223), which contains the Bombyx mori signal sequence fused to the AaIT sequence, has been deposited with the American type culture collection and designated “ATCC 40906.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 10, 2004
    Assignees: The Regents of the Unviersity of California, BASF Aktiengesellschaft
    Inventors: Eliahu Zlotkin, Susumu Maeda, Billy Fred McCutchen, Bruce D. Hammock, Elizabeth Fowler, Rama M. Belagaje
  • Patent number: 6688071
    Abstract: An anchor rod having at least one section provided with ribs or other raised portions or profiling and a threaded section at one or both ends, and having a variable transition section between the threaded section(s) and the profiled section; and a method of making the anchor rod.
    Type: Grant
    Filed: February 13, 2002
    Date of Patent: February 10, 2004
    Assignee: Connector Vinkeveen B.V.
    Inventors: Hermanus Johannes Josef Evers, Robertus Cornelis Maria Van Rijn
  • Patent number: 6691165
    Abstract: A scalable, distributed, highly available, load balancing server system having multiple machines is provided that functions as a front server layer between a network (such as the Internet) and a back-end server layer having multiple machines functioning as Web file servers, FTP servers, or other application servers. The front layer machines comprise a server cluster that performs fail-over and dynamic load balancing for both server layers. The operation of the servers on both layers is monitored, and when a server failure at either layer is detected, the system automatically shifts network traffic from the failed machine to one or more operational machines, reconfiguring front-layer servers as needed without interrupting operation of the server system. The server system automatically accommodates additional machines in the server cluster, without service interruption. The system operates with a dynamic reconfiguration protocol that permits reassignment of network addresses to the front layer machines.
    Type: Grant
    Filed: April 12, 2000
    Date of Patent: February 10, 2004
    Assignee: RAINfinity, Inc.
    Inventors: Jehoshua Bruck, Vasken Bohossian, Chenggong Fan, Paul LeMahieu, Philip Love
  • Patent number: 6689751
    Abstract: Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs in a mammal.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: February 10, 2004
    Assignee: Genentech, Inc.
    Inventors: Ross G. Clark, Henry B. Lowman, Iain C. A. F. Robinson